Repurposing of Tuberculosis Drug Candidates for the Treatment of Mycobacterium ulcerans Disease
Buruli ulcer (BU) is a chronic necrotizing skin disease caused by Mycobacterium ulcerans. Historically, the disease was treated by surgical excision of the skin lesions, until an 8-week combination therapy of rifampicin and streptomycin was introduced in 2004. This treatment modality was effective...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Alemão |
| Vydáno: |
Swiss Chemical Society
2023-09-01
|
| Edice: | CHIMIA |
| Témata: | |
| On-line přístup: | https://www.chimia.ch/chimia/article/view/7038 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|